The optimal single-dose regimen of rasburicase for management of tumour lysis syndrome in children and adults: a systematic review and meta-analysis.
about
The optimal single-dose regimen of rasburicase for management of tumour lysis syndrome in children and adults: a systematic review and meta-analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The optimal single-dose regime ...... atic review and meta-analysis.
@ast
The optimal single-dose regime ...... atic review and meta-analysis.
@en
type
label
The optimal single-dose regime ...... atic review and meta-analysis.
@ast
The optimal single-dose regime ...... atic review and meta-analysis.
@en
prefLabel
The optimal single-dose regime ...... atic review and meta-analysis.
@ast
The optimal single-dose regime ...... atic review and meta-analysis.
@en
P2093
P2860
P356
P1476
The optimal single-dose regime ...... atic review and meta-analysis.
@en
P2093
P2860
Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.
Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia.
P356
10.1111/JCPT.12479
P577
2016-11-25T00:00:00Z